China has found major buyers for its COVID-19 vaccines in Southeast Asia, even after studies of its Sinovac vaccine have reported wildly divergent efficacy results. The growing acceptance of Beijing’s vaccine without globally-recognized clinical trial results may end up undermining China’s image as a credible vaccine supplier.
Thailand has ordered millions of doses of COVID-19 vaccines from AstraZeneca and Sinovac Biotech. However, misinformation about safety concerns may hinder the country’s planned mass immunization campaign.
It is unclear if Cambodia’s apparent criticism of Chinese coronavirus vaccines is meant to refute the country’s reputation as China’s proxy. If that is the case, then Cambodia needs to do far more to introduce balance to its foreign policy.
With funding and vaccines at his disposal, Jokowi may still be unable to execute a free COVID-19 vaccination program as questions remain among Indonesians about the drugs’ safety and their halal status.